Facebook Twitter LinkedIn Google Plus RSS

Cyclacel announces sale of four patents to Celgene, dismissal of litigation

By ,

Cyclacel Pharmaceuticals Inc., in Berkeley Heights, announced today it will sell Celgene Corp., in Summit, four Cyclacel-owned patents in a $5.5 million deal.

According to an announcement, as a result of the agreement, Cyclacel and Celgene have filed a joint stipulation and order for dismissal requesting the court enter an order dismissing a patent litigation dispute between the companies.

You May Have Missed...

Write to the Editorial Department at editorial@njbiz.com

Leave a Comment


Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy


Subscribe to Our Newsletters!
Click Here to Subscribe for Free Now!